Tokyo, Japan

Katsuhiko Sakurada

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuhiko Sakurada. Retrieved from https://idiyas.com/inventor/katsuhiko-sakurada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Katsuhiko Sakurada

Introduction

Katsuhiko Sakurada is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development efforts.

Latest Patents

Sakurada holds a patent for an 8-substituted isoquinoline derivative and its applications. This invention relates to a compound represented by a specific formula, which exhibits IKKβ inhibiting activity. The compound or its salt is useful for the prevention and treatment of diseases or symptoms associated with IKKβ.

Career Highlights

Katsuhiko Sakurada is affiliated with Asahi Kasei Pharma Corporation, where he continues to advance his research in pharmaceutical innovations. His work has the potential to impact various therapeutic areas significantly.

Collaborations

Sakurada collaborates with esteemed colleagues, including Shunsuke Kaneko and Kenichiro Sato, to further enhance the scope and application of his inventions.

Conclusion

Katsuhiko Sakurada's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…